Totient
Latest round
- Seed
Last raised
- Sep 2020
Total raised
- $10M
Investors
- 5
About Totient
Totient Inc.Founded in 2017 and based in Cambridge, US, Totient Inc. specializes in the development of immune-targeted therapies.Totient Inc. specializes in immune profiling to facilitate the discovery of T cell therapies, focusing on personalized medicine approaches.Totient Inc. generates revenue through strategic collaborations with biopharmaceutical companies, focusing on immune-targeted therapy development. aims to expand its product portfolio, specifically targeting new immune profiling products and launching them within the next 12 to 18 months. The company is also looking to penetrate international markets, particularly in Europe and Asia, by 2023.
Who invested in Totient
5 investors across 1 round
See all investors in Totient
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 10, 2020
Amount
$10M
Investors
Questions about Totient
Who invested in Totient?
Totient has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Totient raised?
Totient has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Totient last raise money?
Totient's most recent round on record is a Seed, in Sep 2020.
What does Totient do?
Totient is a biotechnology company.
Where is Totient headquartered?
Totient is headquartered in Cambridge, US.
Which VCs invest in companies like Totient?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Totient's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Totient? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.